ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : -46 مورد

Meta-analysis of breast cancer mortality after 13 years of follow-up in breast cancer screening trials

Meta-analysis of breast cancer mortality after 13 years of follow-up in breast cancer screening trials
Malmö II is excluded because follow-up of approximately 13 years was not available; the Swedish Two-County (Kopparberg and Östergötland) and Canada I and II trials are split into their component parts; the Edinburgh trial is excluded because of severe imbalances between randomized groups. Weights are from random-effects analysis.
RR: relative risk.
Reproduced from: Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380:1778. Illustration used with the permission of Elsevier Inc. All rights reserved.
Graphic 94373 Version 3.0